These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26514378)

  • 1. Exploring Massachusetts Health Care Reform Impact on Fee-for-Service-Funded Substance Use Disorder Treatment Providers.
    Fields D; Pruett J; Roman PM
    J Psychoactive Drugs; 2015; 47(5):417-25. PubMed ID: 26514378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massachusetts Substance Use Disorder Treatment Organizations' Perspectives on the Affordable Care Act: Changes in Payment, Services, and System Design.
    Quinn AE; Stewart MT; Brolin M; Horgan CM; Lane NE
    J Psychoactive Drugs; 2017; 49(2):151-159. PubMed ID: 28350232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance Use Treatment Provider Behavior and Healthcare Reform: Evidence from Massachusetts.
    Maclean JC; Saloner B
    Health Econ; 2018 Jan; 27(1):76-101. PubMed ID: 28224675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and impact of bundled payment for detox and follow-up care.
    Quinn AE; Hodgkin D; Perloff JN; Stewart MT; Brolin M; Lane N; Horgan CM
    J Subst Abuse Treat; 2017 Nov; 82():113-121. PubMed ID: 29021109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract.
    Stuart EA; Barry CL; Donohue JM; Greenfield SF; Duckworth K; Song Z; Mechanic R; Kouri EM; Ebnesajjad C; Chernew ME; Huskamp HA
    Addiction; 2017 Jan; 112(1):124-133. PubMed ID: 27517740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and Challenges for Payment Reform: Observations from Massachusetts.
    Mechanic RE
    J Health Polit Policy Law; 2016 Aug; 41(4):743-62. PubMed ID: 27127259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act.
    Buck JA
    Health Aff (Millwood); 2011 Aug; 30(8):1402-10. PubMed ID: 21821557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bundled payment.
    Mukherji SK; Fockler T
    J Am Coll Radiol; 2014 Jun; 11(6):566-71. PubMed ID: 24787573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts.
    Pande AH; Ross-Degnan D; Zaslavsky AM; Salomon JA
    Am J Prev Med; 2011 Jul; 41(1):1-8. PubMed ID: 21665057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of perceived need and health insurance in substance use treatment: implications for the Affordable Care Act.
    Ali MM; Teich JL; Mutter R
    J Subst Abuse Treat; 2015 Jul; 54():14-20. PubMed ID: 25753655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorder patient privacy and comprehensive care in integrated health care settings.
    Schaper E; Padwa H; Urada D; Shoptaw S
    Psychol Serv; 2016 Feb; 13(1):105-9. PubMed ID: 26845493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massachusetts's experience suggests coverage alone is insufficient to increase addiction disorders treatment.
    Capoccia VA; Grazier KL; Toal C; Ford JH; Gustafson DH
    Health Aff (Millwood); 2012 May; 31(5):1000-8. PubMed ID: 22566439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Diversification as A Management Strategy in Substance Use Disorder Treatment Organizations.
    Fields D; Riesenmy K; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():63-9. PubMed ID: 26021404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased use of the emergency department after health care reform in Massachusetts.
    Smulowitz PB; O'Malley J; Yang X; Landon BE
    Ann Emerg Med; 2014 Aug; 64(2):107-15, 115.e1-3. PubMed ID: 24656759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient hospitalization for substance use disorders one year after residential rehabilitation: predictors among US veterans.
    Chang G; Martin KB; Tang M; Fleming JA
    Am J Drug Alcohol Abuse; 2016; 42(1):56-62. PubMed ID: 26485005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient turnover and nursing employment in Massachusetts hospitals before and after health insurance reform: implications for the Patient Protection and Affordable Care Act.
    Shindul-Rothschild J; Gregas M
    Policy Polit Nurs Pract; 2013; 14(3-4):151-62. PubMed ID: 24658647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital Utilization and Universal Health Insurance Coverage: Evidence from the Massachusetts Health Care Reform Act.
    Cseh A; Koford BC; Phelps RT
    Appl Health Econ Health Policy; 2015 Dec; 13(6):627-35. PubMed ID: 26037893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.